The cost of the patient-day during COVID-19

Introduction: In 2020, an exponential growth and accelerated expansion of COVID-19 was observed. Cuba had 20 hospitals ready for medical care, some 5,000 hospital beds and 477 intensive therapy beds. Objective: Describe the cost of the main assistance and logistics assurance services during the response to COVID-19. Methods: A descriptive and prospective study was carried out in 363 patients, between March 12 and May 30, 2020. The variables studied were patient-day, bed-day, medications, medical supplies, food, clothing, cost per salary and energy power consumed. To obtain the total cost of a patient-day, the fixed and variable costs were added, expressed in Cuban pesos CUP. Results: In the COVID-suspects patient ward, a high number of patient-day (14 578) and a low number of bed-day (5 976) were observed. The average cost per salary was higher in nursing (226,2 CUP). Medications generated at high cost (35,6 %). In April, the highest electricity consumption was recorded (36,6 %) and a cost of 18,071.1 CUP. In relation to the total number of patient-day, an increase in fixed costs (87,30 %) was observed over the variables. Conclusions: The analysis of the cost of patient day-during the COVID-19 pandemic allowed to detail, by hospitalization wards, how much the expenses vary between healthcare services and logistics assurance, as well as the differences between fixed and variable costs. © 2021, Editorial Ciencias Medicas. All rights reserved.

The covid-19 in a leukemic patient

Introduction: The COVID-19 characterizes itself fundamentally for fever and respiratory symptoms. Acute myeloid leukemia represent close to 80 % of the intense leukemias in adults. A patient with leukemia and infected with the SARS-CoV-2, has increased risk of complications and mortality. The commitment of immunity and the effects of the treatment are variable determining in the defensive answer. Objective: Introducing a patient with acute non lymphocytic leukemia, infected by the COVID-19, yielded condition with very uncommonness. Case: A patient with acute non lymphocytic leukemia reports himself, would refract the treatment, cherished at a hospitable institution to present fever and a perianal abscess, next started with humid cough and whitish expectoration. Accomplishes three for him test fast fort he COVID-19 diagnosis, with negative results, and a PCR-RT positive. The hemorrhage, pulmonary sepsis and the state of shock were the principal complications. The patient perishes after a torpid evolution. Conclusions: The authors accord that coexistence of the COVID-19 and acute non lymphocytic leukemia generated potentially lethal complications during the sick person's clinical evolution, associates to the present inmunosupression. © 2020, Editorial Ciencias Medicas. All rights reserved.

Complications of the covid-19 in a hypertensive patient

Introduction: The rapid expansion of COVID-19 caused the World Health Organization, on January 30, 2020, to declare it a health emergency and recognized it as a pandemic on March 11 of the same year. Objective: To describe the clinical evolution of a hypertensive patient, affected by COVID-19. Clinical case: This is a 49-year-old patient, hypertensive, affected by COVID-19, treated at the Dr. “Joaquín Castillo Duany” Military Hospital, who during his stay in the intensive care unit, suffered serious complications such as: Acute respiratory distress syndrome, pneumonia associated with mechanical artificial ventilation, and pulmonary thromboembolism. The delay in going to the hospital, arterial hypertension, and previous treatment with angiotensin-converting enzyme inhibitors, were among the variables present in this patient, which possibly had a negative impact on his evolution. Conclusion: With intensive treatment, the ventilatory and anticoagulation strategy used, evolved favorably until his hospital discharge. © 2020, Editorial Ciencias Medicas. All rights reserved.